The Latest Cardiac and Vascular News
Dr. Egeland is a Founding Partner of Big Sky Biomedical and will transition from Advisor to Managing Director in his new role. MINNEAPOLIS (PRWEB) MARCH 07, 2022 Big Sky Biomedical, a leading-edge medical device and health technology incubator, announced today that it has appointed Ryan Egeland, M.D., Ph.D., M.B.A., as Managing […]
AI heart and lung disease screening solution top-ranked in the medical devices category, joins the likes of Canva, Microsoft, SpaceX, and more OAKLAND, Calif., March 8, 2022 /PRNewswire/ — Eko, a digital health company advancing heart and lung disease detection, has been named to Fast Company‘s annual list of the World’s Most Innovative Companies for 2022 in […]
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 8 March 2022, 7:00 am CET Ghent, Belgium, 8 March 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the […]
– CGuard™ Revenue Generated 87.5% growth over Q4’20 and 55.9% Year-over-Year –- – Published CGuard Clinical trial results in Journals of the American College of Cardiology – – Established Reimbursement Approval for CGuard from the French National Authority – – CGuard Included as Carotid Stent Treatment Option in National Institute […]
– Fifteen Patients Enrolled to Date in Cohort 4 of EnACT (all oral induction regimen); Topline Interim Data Expected Q3 2022 – – Potential Pathway to NDA Submission for MAT2203 with Confirmatory Data to Come from Cohort 5 of EnACT Trial – – Second in vivo Study of Oral LNC-remdesivir […]
Virtual-First Cardiology Company, Heartbeat Health, Achieves SOC 2® Security Control Compliance Certification, Reinforcing Its Commitment to Healthcare Data Security & Privacy. NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) — Heartbeat Health, a Virtual-First Cardiology company that leverages data, device connectivity, and clinicians to deliver on-demand cardiovascular services, announced today that […]
VILLEPINTE, France, March 7, 2022 /PRNewswire/ — Guerbet (FR0000032526 GBT), a global leader in medical imaging, announces it will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available. The company obtained its original offering of 18 references of SeQure® […]
– Reports Promising Early Data from Lead Clinical Program, JK07, for the Treatment of Heart Failure with Reduced Ejection Fraction – – Initiates Enrollment in Second Cohort of JK07 Phase 1 Dose Escalation Study – GAITHERSBURG, Md.–(BUSINESS WIRE)–Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel […]
– The breakthrough approval expands the existing indication of Jardiance® to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe – European marketing authorization follows the U.S. Food and Drug Administration (FDA)’s approval received on 24 February 2022 […]
This week on Investor Insights, host Ken Dropiewski interviews James Eadie, Managing Director of Santé Ventures. They discuss a number of topics including James’s journey into Santé Ventures, Santé’s portfolio, and the working relationship between Santé and early stage companies.
